Skip to content
Recall Observatory FDA recall evidence

Drug product

0.5% Bupivacaine Hydrochloride Injection, USP, 150 mg/30 mL (5 mg/mL), 30 mL Single-dose Teartop Vials (NDC 0409-1162-19), packaged in 25 vials per tray (NDC 0409-1162-02), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA.

D-0626-2021

May 03, 2021

Class I

Product summary

Firm
PFIZER, INC
Event
Event 87837
Status
Terminated
Classification
Class I
Quantity
163,957 vials
Official record key
drug-enforcement:D-0626-2021

Official wording

Reason: Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP

Code information: Lot EG6023, Exp. 07/01/2022

Distribution pattern: Nationwide in the USA, Puerto Rico, and Guam

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Label Mix-Up